NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/02/2023
Back to search
Official data from USPTO
SWANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
05/02/2023
Trademark type
Combined
Nice classes
1, 42
Filing date
11/29/2021
Registration date
05/02/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/02/2023
Last transaction
05/02/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Burgdorf, CH
Examiner
LEHKER, DAWN
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized geometric design consisting of a tall green line curving slightly to the right with a short green line curving to the right under the top of the tall green line. To the left of the tall green line are two blue lines, curving slightly to the left with one above the other. To the right of the tall green line is a short blue line, curving left, so that it appears the green line bisects a blue line. To the right of the design is the stylized word "swant" in blue lettering.
Holders and representatives
Holders
Swant (Swiss antibodies) AG
Representatives
Todd A. Sullivan HAYES SOLOWAY PC
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Monoclonal antibodies for scientific use; tagged antibodies for scientific use; tagged antibodies for laboratory use; monoclonal antibodies for diagnostic use in a scientific or laboratory settingfor use in diagnosing neuroscience diseases and disordersmuscular diseases and disorderscardiovascular diseases and disorderskidney diseases and disorderscancerhypertensionimmunityendocrine diseases and disordersdiabetesnot for medical use
Class 42
Research and development in the field of antibodies
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/02/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/14/2023
PUBO
PUBLISHED FOR OPPOSITION
02/14/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/25/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2023
ALIE
ASSIGNED TO LIE
12/30/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/03/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/31/2022
GNSL
LETTER OF SUSPENSION E-MAILED
10/31/2022
CNSL
SUSPENSION LETTER WRITTEN
10/31/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/28/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/27/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/27/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/09/2022
GNRT
NON-FINAL ACTION E-MAILED
09/09/2022
CNRT
NON-FINAL ACTION WRITTEN
09/09/2022
DOCK
ASSIGNED TO EXAMINER
09/08/2022
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/02/2021
NWAP
NEW APPLICATION ENTERED
12/02/2021
Continuous trademark protection
Get notified about every new filing that threatens SWANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.